{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:06Z","timestamp":1772119986044,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia\u2014","award":["SC (SFRH\/BD\/147650\/2019)."],"award-info":[{"award-number":["SC (SFRH\/BD\/147650\/2019)."]}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cytosine modifications at the 5-carbon position play a critical role in gene expression regulation and have been implicated in cancer development. 5-Hydroxymethylcytosine (5hmC), arising from 5-methylcytosine (5-mC) oxidation, has shown promise as a potential malignancy marker due to its depletion in various human cancers. However, its significance in thyroid tumors remains underexplored, primarily due to limited data. In our study, we evaluated 5hmC expression levels by immunohistochemistry in a cohort of 318 thyroid tumors. Our analysis revealed significant correlations between 5hmC staining extension scores and nodule size, vascular invasion, and oncocytic morphology. Nuclear 5hmC staining intensity demonstrated associations with focality, capsule status, extrathyroidal extension, vascular invasion, and oncocytic morphology. Follicular\/oncocytic adenomas exhibited higher 5hmC expression than uncertain malignant potential (UMP) or noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP), as well as malignant neoplasms, including papillary thyroid carcinomas (PTCs), oncocytic carcinomas (OCAs), follicular thyroid carcinomas (FTCs), and invasive encapsulated follicular variants of PTC (IEFV-PTC).\n                    <jats:italic>TERT<\/jats:italic>\n                    promoter mutation cases showed notably lower values for the 5hmC expression, while\n                    <jats:italic>RAS<\/jats:italic>\n                    (\n                    <jats:italic>H<\/jats:italic>\n                    ,\n                    <jats:italic>N<\/jats:italic>\n                    , or\n                    <jats:italic>K<\/jats:italic>\n                    ) mutations, particularly\n                    <jats:italic>HRAS<\/jats:italic>\n                    mutations, were associated with higher 5hmC expression. Additionally, we identified, for the first time, a significant link between 5hmC expression and oncocytic morphology. However, despite the merits of these discoveries, we acknowledge that 5hmC currently cannot segregate minimally invasive from widely invasive tumors, although 5hmC levels were lower in wi-FPTCs. Further research is needed to explore the potential clinical implications of 5hmC in thyroid tumors.\n                  <\/jats:p>","DOI":"10.1007\/s12022-024-09800-9","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T07:02:40Z","timestamp":1706511760000},"page":"25-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Role of 5-Hydroxymethylcytosine as a Potential Epigenetic Biomarker in a Large Series of Thyroid Neoplasms"],"prefix":"10.1007","volume":"35","author":[{"given":"Sule","family":"Canberk","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"Elisabete","family":"Rios","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nia A.","family":"Povoa","sequence":"additional","affiliation":[]},{"given":"Ebru","family":"Tastekin","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Aysun","family":"Uguz","sequence":"additional","affiliation":[]},{"given":"Ozlem","family":"Aydin","sequence":"additional","affiliation":[]},{"given":"Umit","family":"Ince","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Valdemar","family":"M\u00e1ximo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"6","key":"9800_CR1","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","volume":"150","author":"CG Lian","year":"2012","unstructured":"Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135-46.","journal-title":"Cell."},{"issue":"9","key":"9800_CR2","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1182\/blood-2010-12-324707","volume":"118","author":"E Pronier","year":"2011","unstructured":"Pronier E, Almire C, Mokrani H, Vasanthakumar A, Simon A, da Costa Reis Monte Mor B, et al. Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood. 2011;118(9):2551\u20135.","journal-title":"Blood"},{"issue":"7","key":"9800_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/ijc.27429","volume":"131","author":"TF Kraus","year":"2012","unstructured":"Kraus TF, Globisch D, Wagner M, Eigenbrod S, Widmann D, Munzel M, et al. Low values of 5-hydroxymethylcytosine (5hmC), the \u201csixth base,\u201d are associated with anaplasia in human brain tumors. Int J Cancer. 2012;131(7):1577-90.","journal-title":"Int J Cancer."},{"issue":"4","key":"9800_CR4","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s13277-014-2900-2","volume":"36","author":"ZR Dong","year":"2015","unstructured":"Dong ZR, Zhang C, Cai JB, Zhang PF, Shi GM, Gao DM, et al. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma. Tumour Biol. 2015;36(4):2763-71.","journal-title":"Tumour Biol."},{"issue":"6","key":"9800_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-17-1958","volume":"24","author":"DW Tucker","year":"2018","unstructured":"Tucker DW, Getchell CR, McCarthy ET, Ohman AW, Sasamoto N, Xu S, et al. Epigenetic Reprogramming Strategies to Reverse Global Loss of 5-Hydroxymethylcytosine, a Prognostic Factor for Poor Survival in High-grade Serous Ovarian Cancer. Clin Cancer Res. 2018;24(6):1389-401.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"9800_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30146","volume":"69","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang J, Mo J, Liu D, Cao D, Wang H, et al. Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma. Hepatology. 2019;69(1):196-208.","journal-title":"Hepatology."},{"issue":"3","key":"9800_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.gpb.2018.06.002","volume":"16","author":"J Zhang","year":"2018","unstructured":"Zhang J, Han X, Gao C, Xing Y, Qi Z, Liu R, et al. 5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer. Genomics Proteomics Bioinformatics. 2018;16(3):187-99.","journal-title":"Genomics Proteomics Bioinformatics."},{"issue":"3","key":"9800_CR8","first-page":"2304","volume":"18","author":"M Tong","year":"2019","unstructured":"Tong M, Gao S, Qi W, Shi C, Qiu M, Yang F, et al. 5-Hydroxymethylcytosine as a potential epigenetic biomarker in papillary thyroid carcinoma. Oncol Lett. 2019;18(3):2304-9.","journal-title":"Oncol Lett."},{"issue":"4","key":"9800_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/1066896920978597","volume":"29","author":"JY Seok","year":"2021","unstructured":"Seok JY, Astvatsaturyan K, Peralta-Venturina M, Lai J, Fan X. TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma. Int J Surg Pathol. 2021;29(4):368-77.","journal-title":"Int J Surg Pathol."},{"key":"9800_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2022.151903","volume":"57","author":"JY Seok","year":"2022","unstructured":"Seok JY, Fan X. TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae. Ann Diagn Pathol. 2022;57:151903.","journal-title":"Ann Diagn Pathol."},{"issue":"4","key":"9800_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12022-020-09652-z","volume":"31","author":"N Oishi","year":"2020","unstructured":"Oishi N, Vuong HG, Mochizuki K, Kondo T. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations. Endocr Pathol. 2020;31(4):359-66.","journal-title":"Endocr Pathol."},{"key":"9800_CR12","first-page":"-","volume":"221554231190437","author":"M Hysek","year":"2023","unstructured":"Hysek M, Hellgren SL, Condello V, Xu Y, Larsson C, Zedenius J, Juhlin CC. 5hmC Immunohistochemistry: A Predictor of TERT Promoter Mutational Status in Follicular Thyroid Carcinoma? J Histochem Cytochem. 2023;221554231190437.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"9800_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, et al. Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol. 2022;33(1):27-63.","journal-title":"Endocr Pathol."},{"issue":"9","key":"9800_CR14","doi-asserted-by":"publisher","first-page":"-","DOI":"10.3390\/cancers13092048","volume":"13","author":"AA Povoa","year":"2021","unstructured":"Povoa AA, Teixeira E, Bella-Cueto MR, Batista R, Pestana A, Melo M, et al. Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma. Cancers (Basel). 2021;13(9).","journal-title":"Cancers (Basel)"},{"key":"9800_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fgene.2017.00100","volume":"8","author":"DQ Shi","year":"2017","unstructured":"Shi DQ, Ali I, Tang J, Yang WC. New Insights into 5hmC DNA Modification: Generation, Distribution and Function. Front Genet. 2017;8:100.","journal-title":"Distribution and Function. Front Genet."},{"issue":"7472","key":"9800_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472-9.","journal-title":"Nature."},{"issue":"7576","key":"9800_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature15713","volume":"527","author":"L Hu","year":"2015","unstructured":"Hu L, Lu J, Cheng J, Rao Q, Li Z, Hou H, et al. Structural insight into substrate preference for TET-mediated oxidation. Nature. 2015;527(7576):118-22.","journal-title":"Nature."},{"issue":"1","key":"9800_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40246-020-00265-5","volume":"14","author":"T Xu","year":"2020","unstructured":"Xu T, Gao H. Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment? Hum Genomics. 2020;14(1):15.","journal-title":"Hum Genomics."},{"key":"9800_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13148-016-0197-2","volume":"8","author":"E Barazeghi","year":"2016","unstructured":"Barazeghi E, Gill AJ, Sidhu S, Norlen O, Dina R, Palazzo FF, et al. 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma. Clin Epigenetics. 2016;8:31.","journal-title":"Clin Epigenetics."},{"issue":"5","key":"9800_CR20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jjco\/hyw002","volume":"46","author":"LY Zhang","year":"2016","unstructured":"Zhang LY, Han CS, Li PL, Zhang XC. 5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma. Jpn J Clin Oncol. 2016;46(5):427-34.","journal-title":"Jpn J Clin Oncol."},{"key":"9800_CR21","unstructured":"Tuttle M, Morris L, Haugen B, Shah J, Sosa J, Rohren E, et al. Thyroid-differentiated and anaplastic carcinoma (Chapter 73): Springer International Publishing; 2017."},{"issue":"9","key":"9800_CR22","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1245\/s10434-009-0565-7","volume":"16","author":"JD Lin","year":"2009","unstructured":"Lin JD, Chao TC, Hsueh C, Kuo SF. High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol. 2009;16(9):2609-16.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"9800_CR23","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1007\/s13277-015-4533-5","volume":"37","author":"N Qu","year":"2016","unstructured":"Qu N, Zhang L, Wu WL, Ji QH, Lu ZW, Zhu YX, Lin DZ. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer. Tumour Biol. 2016;37(7):8783-9.","journal-title":"Tumour Biol."},{"issue":"7","key":"9800_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00018-022-04396-x","volume":"79","author":"K Joshi","year":"2022","unstructured":"Joshi K, Liu S, Breslin SJP, Zhang J. Mechanisms that regulate the activities of TET proteins. Cell Mol Life Sci. 2022;79(7):363.","journal-title":"Cell Mol Life Sci."},{"issue":"3","key":"9800_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11060-022-04172-8","volume":"162","author":"DD Shi","year":"2023","unstructured":"Shi DD, Anand S, Abdullah KG, McBrayer SK. DNA damage in IDH-mutant gliomas: mechanisms and clinical implications. J Neurooncol. 2023;162(3):515-23.","journal-title":"J Neurooncol."},{"issue":"3","key":"9800_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2010.02.095","volume":"393","author":"AK Murugan","year":"2010","unstructured":"Murugan AK, Bojdani E, Xing M. Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer. Biochem Biophys Res Commun. 2010;393(3):555-9.","journal-title":"Biochem Biophys Res Commun."},{"issue":"12","key":"9800_CR27","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26(12):1326-38.","journal-title":"Genes Dev."},{"issue":"4","key":"9800_CR28","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/ERC-11-0354","volume":"19","author":"V Maximo","year":"2012","unstructured":"Maximo V, Lima J, Prazeres H, Soares P, Sobrinho-Simoes M. The biology and the genetics of Hurthle cell tumors of the thyroid. Endocr Relat Cancer. 2012;19(4):R131-47.","journal-title":"Endocr Relat Cancer."},{"key":"9800_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.674666","volume":"12","author":"S Canberk","year":"2021","unstructured":"Canberk S, Lima AR, Pinto M, Soares P, Maximo V. Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application. Front Endocrinol (Lausanne). 2021;12:674666.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"7","key":"9800_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40618-015-0246-2","volume":"38","author":"S Keelawat","year":"2015","unstructured":"Keelawat S, Thorner PS, Shuangshoti S, Bychkov A, Kitkumthorn N, Rattanatanyong P, et al. Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis. J Endocrinol Invest. 2015;38(7):725-32.","journal-title":"J Endocrinol Invest."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-024-09800-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-024-09800-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T06:35:32Z","timestamp":1710830132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-024-09800-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["9800"],"URL":"https:\/\/doi.org\/10.1007\/s12022-024-09800-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3034402\/v1","asserted-by":"object"}]},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"16 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design was approved by the Ethical Committee of Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o at 16 March 2017 under the Project entitled \u201cDiabetes & obesity at the crossroads between Oncological and Cardiovascular diseases\u2014a system analysis NETwork towards precision medicine (DOCnet).\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}